Is CRA International, Inc. (CRAI) A Good Stock To Buy?

Consequently, some big names have jumped into CRA International, Inc. (NASDAQ:CRAI) headfirst. Algert Coldiron Investors, led by Peter Algert and Kevin Coldiron, created the most valuable position in CRA International, Inc. (NASDAQ:CRAI). Algert Coldiron Investors had $1 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also made a $0.4 million investment in the stock during the quarter. The only other fund with a new position in the stock is Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Let’s also examine hedge fund activity in other stocks similar to CRA International, Inc. (NASDAQ:CRAI). These stocks are Zix Corporation (NASDAQ:ZIXI), Invivo Therapeutics Holdings Corp (NASDAQ:NVIV), Diana Shipping Inc. (NYSE:DSX), and USA Technologies, Inc. (NASDAQ:USAT). This group of stocks’ market values match CRAI’s market value.

As you can see these stocks had an average of eight hedge funds with bullish positions and the average amount invested in these stocks was $16 million. That figure was $37 million in CRAI’s case. Zix Corporation (NASDAQ:ZIXI) is the most popular stock in this table. On the other hand Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) is the least popular one with only four bullish hedge fund positions. CRA International, Inc. (NASDAQ:CRAI) had the same number of funds holding its shares as Zix Corporation, which suggests that it may be a good idea to study it in more detail and potentially including it in your portfolio.

Disclosure: none